# Clinical studies of CRF-PACAP systems in human PTSD (Rosso)

> **NIH NIH P50** · MCLEAN HOSPITAL · 2020 · $794,582

## Abstract

PROJECT 4 (ROSSO LAB): SUMMARY
Post-Traumatic Stress Disorder (PTSD) is a leading cause of global disease burden, and it is twice as common
in women as in men. In addition to female sex, genetic factors are established risk factors for PTSD.
Furthermore, the diagnosis requires exposure to at least one highly traumatizing stressor, which independently
and synergistically with genetic vulnerability leads to long-lasting perturbations in biological arousal systems. A
number of moderators of stress responsiveness may contribute to PTSD, including the differential risk seen in
women. Altered function of corticotropin releasing factor (CRF) and pituitary adenylate cyclase-activating
polypeptide (PACAP) systems represent candidate mechanisms of sex-dependent moderation of PTSD liability.
Higher blood PACAP levels and allelic variation in the gene (ADCYAP1R1) encoding the PAC1R receptor predict
greater anxious arousal symptoms and total symptoms in women with PTSD, and greater physiological arousal
during anxiety-related paradigms. Variation in CRF and its Type-I receptor have also been associated with both
PTSD and depression, and sex differences may produce persistent physiological arousal in women exposed to
severe stress. Importantly, the neurobiological correlates of CRF/PACAP overlap with arousal-related brain
circuitry that is implicated in PTSD, including extended amygdala (extAMG) and medial prefrontal cortex (mPFC).
This project is designed to identify CRF-, PACAP-, CRF+PACAP-predominant intermediate phenotypes in
women and men with PTSD. Two subregions of the extAMG, the amygdala (AMG) and bed nucleus of the stria
terminalis (BNST), will be independently examined, due to evidence of their partially separable roles in fear
versus anxiety, and their potentially differential contributions to PTSD. The mPFC will be a focus as a region
that modulates arousal responses to threat via reciprocal connections with the AMG and BNST. Using blood
samples from adults with DSM-5 PTSD, we will examine CRF and PACAP variation (genetic, epigenetic, mRNA)
in relation to markers of hyperarousal across levels of analysis: (1) blood levels of PACAP and hypothalamic
pituitary adrenal axis hormones (ACTH and cortisol) as indices of CRF function; (2) resting state functional
magnetic resonance imaging of extAMG-mPFC; (4) diffusion tensor imaging of extAMG-mPFC; (5) magnetic
resonance spectroscopy of mPFC glutamate metabolism and neuronal integrity (N-acetylaspartate); (6)
physiological indices of arousal during fear conditioning and dark enhanced startle paradigms; and (7) clinical
symptoms of hyperarousal: anxious arousal, dysphoric arousal, and sleep disruption (using self-report and
actigraphy). Project 4 will enhance our understanding of biobehavioral mechanisms of CRF/PACAP in humans,
with the potential to identify new PTSD biomarkers. Neuroimaging of BNST function and glutamate metabolism
is particularly innovative and may facilitate development of improved diag...

## Key facts

- **NIH application ID:** 9904775
- **Project number:** 5P50MH115874-02
- **Recipient organization:** MCLEAN HOSPITAL
- **Principal Investigator:** ISABELLE M ROSSO
- **Activity code:** P50 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $794,582
- **Award type:** 5
- **Project period:** — → —

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9904775

## Citation

> US National Institutes of Health, RePORTER application 9904775, Clinical studies of CRF-PACAP systems in human PTSD (Rosso) (5P50MH115874-02). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/9904775. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*